Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 25, 2014 (12 years ago)

G.A.C. 375 Injection USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer

Cause type: Unapproved drug

The product was marketed without an approved NDA/ANDA, or does not meet the OTC monograph it claims to follow. Nothing about the product - dose, purity, safety - has been reviewed by FDA, so the claims on the box are unverified. All unapproved drug recalls.

What was recalled

G.A.C. 375 Injection USP, packaged in 30 ml vials, Sterile, For IM or Deep SQ Use, Multiple Dose Vial, Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us.

Recalling firm
Medical Supply Liquidators Llc
Origin
IA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1531-2014 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Medical Supply Liquidators Llc

All 2014 recalls
Class II · Moderate risk

Glutathione Injection USP

Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer

Terminated Unapproved drug Medical Supply Liquidators Llc D-1533-2014
Class II · Moderate risk

L-Carnitine Injection USP 100 mg/ml

Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer

Terminated Unapproved drug Medical Supply Liquidators Llc D-1532-2014
Class II · Moderate risk

Lipo 8 Injection USP 200 mg/ml

Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer

Terminated Unapproved drug Medical Supply Liquidators Llc D-1530-2014

Other unapproved drug recalls from 2014

All unapproved drug recalls
Class II · Moderate risk

B-Lipo

Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss

Terminated Unapproved drug Bethel Nutritional Consulting, Inc D-0424-2015
Class I · High risk

Professional Formexx Black

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0990-2015
Class I · High risk

Swoll-250 Super Mass Builder Quad Stack

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0989-2015
Class I · High risk

Estrastain Pro-Anabolic Mass and Hardening Complex

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0988-2015